Pain management remains a significant challenge in medicine, with ongoing unmet needs and slow progress, according to a discussion released on Jul. 16 by BioSpace. The episode of Denatured features Lance Alstodt, chairman and CEO at BioRestorative Therapies, and Paul Mieyal, chief business officer at South Rampart Pharma.
The conversation examines why advancements in pain treatment have lagged and explores new approaches that could reshape the field. These include non-opioid pathways as well as regenerative therapies aimed at providing effective alternatives for patients.
Jennifer C. Smith-Parker, director of insights at BioSpace, hosts the discussion with Alstodt and Mieyal as guests. Both executives share their perspectives on current barriers in pain management research and highlight the potential impact of innovative treatments.
A disclaimer notes that "the views expressed in this discussion by guests are their own and do not represent those of their organizations." The full episode is available on multiple platforms, including Spotify, Apple Podcasts, Amazon Music, and iHeart.
